Bhk Investment Advisors, LLC Amgen Inc Transaction History

Bhk Investment Advisors, LLC

$255 Million
Q2 2024

A detailed history of Bhk Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bhk Investment Advisors, LLC holds 2,483 shares of AMGN stock, worth $788,302. This represents 0.3% of its overall portfolio holdings.

Number of Shares

2,483

Previous 2,537 2.13%

Holding current value

$788,302

Previous $721,000 7.49%

% of portfolio

0.3%

Previous 0.28%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $14,188 - $17,242	-54 Reduced 2.13%	2,483 $775,000
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $264,836 - $319,691	985 Added 63.47%	2,537 $721,000
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $61,368 - $69,230	-240 Reduced 13.39%	1,552 $447,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $50,070 - $62,164	-229 Reduced 11.33%	1,792 $481,000
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $27,855 - $32,938	130 Added 6.87%	2,021 $448,000
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $91,670 - $111,731	406 Added 27.34%	1,891 $457,000
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $92,757 - $117,859	-405 Reduced 21.43%	1,485 $390,000
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $4,489 - $5,063	-20 Reduced 1.05%	1,890 $426,000
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $65,752 - $73,170	285 Added 17.54%	1,910 $465,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.06%	1,625 $393,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $12,927 - $14,794	65 Added 4.17%	1,624 $365,000
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $3,184 - $3,730	-15 Reduced 0.95%	1,559 $332,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $5,605 - $6,219	-24 Reduced 1.5%	1,574 $384,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $24,883 - $29,632	115 Added 7.75%	1,598 $367,000
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $35,197 - $39,142	150 Added 11.25%	1,483 $377,000
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $9,692 - $11,894	-49 Reduced 3.55%	1,333 $314,000
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $19,135 - $25,378	105 Added 8.22%	1,382 $280,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $75,684 - $97,280	-400 Reduced 23.85%	1,277 $308,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $90,537 - $108,482	-520 Reduced 23.67%	1,677 $325,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $13,669 - $16,023	82 Added 3.88%	2,197 $405,000
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.05%	2,115 $402,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $52,992 - $59,742	286 Added 15.65%	2,114 $438,000
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $303,539 - $340,940	1,828 New	1,828 $337,000

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bhk Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bhk Investment Advisors, LLC with notifications on news.

Account

Bhk Investment Advisors, LLC Amgen Inc Transaction History